                         SEQUENCE LISTING

<110>  Indiana University Research and Technology Corp.
 
<120>  MATERIALS AND METHOD FOR SUPPRESSING INFLAMMATORY AND NEUROPATHIC
        PAIN

<130>  IURTC-P0047-01-PCT

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CBD3

<400>  1

Ala Arg Ser Arg Leu Ala Glu Leu Arg Gly Val Pro Arg Gly Leu 
1               5                   10                  15  


<210>  2
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  control

<400>  2

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Trp Glu Ala Lys Glu 
1               5                   10                  15      


Met Leu Tyr Phe Glu Ala Leu Val Ile Glu 
            20                  25      


<210>  3
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  exemplary polypeptide 2

<400>  3

Ala Arg Ser Arg Ala Ala Glu Leu Arg Gly Val Pro Arg Gly Leu 
1               5                   10                  15  


<210>  4
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  exemplary polypeptide 3

<400>  4

Ala Arg Pro Arg Leu Ala Glu Leu Arg Gly Val Pro Arg Gly Leu 
1               5                   10                  15  


<210>  5
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  exemplary polypeptide 4

<400>  5

Ala Arg Pro Arg Arg Ala Glu Leu Arg Gly Val Pro Arg Gly Leu 
1               5                   10                  15  


<210>  6
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  exemplary polypeptide 5

<400>  6

Ala Arg Ser Arg Leu Ala Glu Leu Arg Arg Val Pro Arg Gly Leu 
1               5                   10                  15  


<210>  7
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  exemplary polypeptide 6

<400>  7

Ala Arg Ser Arg Leu Ala Glu Leu Arg Gly Val Pro Arg Phe Leu 
1               5                   10                  15  


<210>  8
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  exemplary polypeptide 7

<400>  8

Ala Arg Ser Arg Leu Lys Glu Leu Arg Gly Val Pro Arg Gly Leu 
1               5                   10                  15  


<210>  9
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  exemplary polypeptide 8

<400>  9

Ala Arg Ser Arg Leu Ala Asp Leu Arg Gly Val Pro Arg Gly Leu 
1               5                   10                  15  


<210>  10
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  exemplary polypeptide 9

<400>  10

Ala Arg Ser Trp Leu Ala Glu Leu Arg Gly Val Pro Arg Gly Leu 
1               5                   10                  15  


<210>  11
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  TAT plus CBD3

<400>  11

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala Arg Ser Arg Leu 
1               5                   10                  15      


Ala Glu Leu Arg Gly Val Pro Arg Gly Leu 
            20                  25      


<210>  12
<211>  12
<212>  PRT
<213>  Human immunodeficiency virus type 1

<400>  12

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Gln 
1               5                   10          


<210>  13
<211>  11
<212>  PRT
<213>  Human immunodeficiency virus type 1

<400>  13

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


